These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 18679031)

  • 1. Illicit methadone use and abuse in young people accessing treatment for opiate dependence.
    Roche A; McCabe S; Smyth BP
    Eur Addict Res; 2008; 14(4):219-25. PubMed ID: 18679031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors affecting the outcome of methadone maintenance treatment in opiate dependence.
    Kamal F; Flavin S; Campbell F; Behan C; Fagan J; Smyth R
    Ir Med J; 2007 Mar; 100(3):393-7. PubMed ID: 17491538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opiate-dependent patients receiving methadone. How physicians should manage therapy.
    Kahan M; Sutton N
    Can Fam Physician; 1996 Sep; 42():1769-78. PubMed ID: 8828879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of the dose on the severity of opiate withdrawal symptoms during methadone detoxification.
    Glasper A; Gossop M; de Wet C; Reed L; Bearn J
    Pharmacology; 2008; 81(2):92-6. PubMed ID: 17952010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acetyl-L-carnitine in the management of pain during methadone withdrawal syndrome.
    Janiri L; Martinotti G; Tonioni F; Ghelardini C; Nicolai R; Galeotti N; Mosconi L; Calvani M; Bartolini A; Iannoni E
    Clin Neuropharmacol; 2009; 32(1):35-40. PubMed ID: 18978503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Problem drinking in relation to treatment outcome among opiate addicts in methadone maintenance treatment.
    Stenbacka M; Beck O; Leifman A; Romelsjö A; Helander A
    Drug Alcohol Rev; 2007 Jan; 26(1):55-63. PubMed ID: 17364837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with the prescribing of buprenorphine or methadone for treatment of opiate dependence.
    Ridge G; Gossop M; Lintzeris N; Witton J; Strang J
    J Subst Abuse Treat; 2009 Jul; 37(1):95-100. PubMed ID: 19004598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of buprenorphine and methadone in the treatment of opiate withdrawal: possible advantages of buprenorphine for the treatment of opiate-benzodiazepine codependent patients?
    Reed LJ; Glasper A; de Wet CJ; Bearn J; Gossop M
    J Clin Psychopharmacol; 2007 Apr; 27(2):188-92. PubMed ID: 17414244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users.
    Banta-Green CJ; Maynard C; Koepsell TD; Wells EA; Donovan DM
    Addiction; 2009 May; 104(5):775-83. PubMed ID: 19344438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Slow-release oral morphine for maintenance treatment of opioid addicts intolerant to methadone or with inadequate withdrawal suppression.
    Kastelic A; Dubajic G; Strbad E
    Addiction; 2008 Nov; 103(11):1837-46. PubMed ID: 19032534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, open-label trial comparing methadone and Levo-Alpha-Acetylmethadol (LAAM) in maintenance treatment of opioid addiction.
    Wolstein J; Gastpar M; Finkbeiner T; Heinrich C; Heitkamp R; Poehlke T; Scherbaum N
    Pharmacopsychiatry; 2009 Jan; 42(1):1-8. PubMed ID: 19153939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-patient detoxification procedures, treatment retention, and post-treatment opiate use: comparison of lofexidine + naloxone, lofexidine + placebo, and methadone.
    McCambridge J; Gossop M; Beswick T; Best D; Bearn J; Rees S; Strang J
    Drug Alcohol Depend; 2007 Apr; 88(1):91-5. PubMed ID: 17064857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benzodiazepine co-dependence exacerbates the opiate withdrawal syndrome.
    de Wet C; Reed L; Glasper A; Moran P; Bearn J; Gossop M
    Drug Alcohol Depend; 2004 Oct; 76(1):31-5. PubMed ID: 15380286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lapse and relapse following inpatient treatment of opiate dependence.
    Smyth BP; Barry J; Keenan E; Ducray K
    Ir Med J; 2010 Jun; 103(6):176-9. PubMed ID: 20669601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of methadone in the treatment of opiate addicts: current findings in the literature].
    Matot JP; Zombek S
    Rev Med Brux; 1991; 12(1-2):3-8. PubMed ID: 1849665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for preterm birth among opiate-addicted gravid women in a methadone treatment program.
    Almario CV; Seligman NS; Dysart KC; Berghella V; Baxter JK
    Am J Obstet Gynecol; 2009 Sep; 201(3):326.e1-6. PubMed ID: 19631928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous and intranasal heroin-dependent treatment-seekers: characteristics and treatment outcome.
    Highfield DA; Schwartz RP; Jaffe JH; O'Grady KE
    Addiction; 2007 Nov; 102(11):1816-23. PubMed ID: 17784892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Management of opiate-dependent adolescents in the Vaud canton. Reflections on the indication for treatment with methadone].
    Savoy J; Laget J; Charpentier P; Sanchez-Mazas P; Besson J; Halfon O
    Rev Med Suisse Romande; 1999 Nov; 119(11):943-50. PubMed ID: 10628219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Auricular acupuncture as an adjunct to opiate detoxification treatment: effects on withdrawal symptoms.
    Bearn J; Swami A; Stewart D; Atnas C; Giotto L; Gossop M
    J Subst Abuse Treat; 2009 Apr; 36(3):345-9. PubMed ID: 19004596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A national study of the retention of Irish opiate users in methadone substitution treatment.
    Mullen L; Barry J; Long J; Keenan E; Mulholland D; Grogan L; Delargy I
    Am J Drug Alcohol Abuse; 2012 Nov; 38(6):551-8. PubMed ID: 22747484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.